editedbook
REGULATORY STRATEGY FOR PRODUCT DEVELOPMENT AND LIFE CYCLE MANAGEMENT: A REVIEW
Area/Stream: Pharmacy & Nursing,
Authors: Vaishali Patel, Rajashri Chaudhari, Pratima Patel, Kinjal Parmar
Keywords: Product development, Life cycle management, Drug discovery, Regulation bodies, Intellectual property rights
Book Name /series: Futuristic Trends in Pharmacy & Nursing,Volume 2, Book 25, Part 1, Chapter 17
Publication: IIP Proceedings
Year: 2022,
Month: November
Page No: 193-206,
ISSN/ISBN: 978-93-95632-87-4,
DOI/Link: https://rsquarel.org/assets/docupload/rsl20236041F70F34D03AC.pdf
Abstract:
More effective drug development and manufacture are required due to the complexity of the pharmaceutical market today. Even in this extremely complicated environment, Product Lifecycle Management (PLM) offers the potential to increase the effectiveness and reduce the risk of pharmaceutical production.[1] From an initial idea to the final retreat, the product lifecycle management develops and oversees a company's product-related intellectual capital. It helps the pharmaceutical sector by extending the life of patents and improving pricing tactics.[2] Among the key applications of product lifecycle management are increased patient compliance, revenue growth, extended clinical benefits, cost advantages, life extension exclusivity, and quicker market launch.[3] Less difficulties, lower costs, higher yields, personnel equipped to make wise decisions, and audits that make everyone more accountable are all advantages that leaders are actively pursuing through the implementation of PLM.[4-6]
Cite this: Vaishali Patel, Rajashri Chaudhari, Pratima Patel, Kinjal Parmar,"REGULATORY STRATEGY FOR PRODUCT DEVELOPMENT AND LIFE CYCLE MANAGEMENT: A REVIEW", Futuristic Trends in Pharmacy & Nursing,Volume 2, Book 25, Part 1, Chapter 17, November, 2022, 193-206, 978-93-95632-87-4, https://rsquarel.org/assets/docupload/rsl20236041F70F34D03AC.pdf